Introduction of Stock Options for Directors and Executive Officers
First written in FY2022. 9 of 11 entries say "Advanced", first in FY2023-Q2. Latest entry: FY2027-H1.
- FY2027-H1AdvancedAnnual report
「Name of stock acquisition rights: Fifth Series of Stock Acquisition Rights / Resolution date: 7 August 2026 (Board of Directors resolution) / Category and number of eligible persons (people): Executive Officers 2 / Number of stock acquisition rights (units): 200 / Class, content and number of shares underlying the stock acquisition rights (shares): Common shares 20,000 / Exercise period for stock acquisition rights: 8 August 2028 to 7 August 2036」
Specific details of the stock incentive for officers and other eligible persons were disclosed, including the grant of 200 Fifth Series stock acquisition rights, representing 20,000 underlying shares, to 2 Executive Officers. - FY2026AdvancedAnnual report
「Exercised: 60,900 / Outstanding and unexercised: 148,100」
For the First Stock Acquisition Rights, 60,900 shares were exercised during the fiscal year, leaving 148,100 unexercised shares at the end of the period. A further 5,500 shares underlying the Second Stock Acquisition Rights were exercised, indicating that the equity incentive for directors and executive officers has progressed to the exercise stage. - FY2026-H1AdvancedAnnual report
「Name of stock acquisition rights: Fourth Stock Acquisition Rights / Resolution date: 7 August 2025 (Board of Directors resolution) / Category and number of grantees (people): 6 executive officers / Number of stock acquisition rights (units): 600 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 60,000 / Exercise period: 8 August 2027 to 7 August 2035」
The specific terms of the equity incentive for officers and others were disclosed: 600 Fourth Stock Acquisition Rights, representing 60,000 underlying shares, were granted to 6 executive officers. - FY2025AdvancedAnnual report
「Vested: 330,000 / Exercised: 121,000 / Outstanding and unexercised: 209,000」
For the First Stock Acquisition Rights, 330,000 shares vested and 121,000 shares were exercised during the fiscal year. Including the grant of 10,000 shares underlying the Third Stock Acquisition Rights, the equity incentive for directors and executive officers was updated as it entered the implementation stage. - FY2025-H1AdvancedAnnual report
「Name of stock acquisition rights: Third Stock Acquisition Rights / Resolution date: 8 August 2024 (Board of Directors resolution) / Category and number of grantees (people): 1 executive officer / Number of stock acquisition rights (units): 100 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 10,000」
The specific terms of the equity incentive for officers and others were disclosed: 100 Third Stock Acquisition Rights, representing 10,000 underlying shares, were granted to 1 executive officer. The exercise period runs from 9 August 2026 to 8 August 2034. - FY2024-Q2AdvancedAnnual report
「Name of stock acquisition rights: Second Stock Acquisition Rights / Resolution date: 9 August 2023 (Board of Directors resolution) / Category and number of grantees (people): 3 executive officers / Number of stock acquisition rights (units): 300 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 30,000 / Exercise period: 10 August 2025 to 9 August 2033」
The specific terms of the equity incentive for officers and others were resolved and disclosed: 300 Second Stock Acquisition Rights, representing 30,000 underlying shares, were granted to 3 executive officers. - FY2023AchievedAnnual report
「Name of stock acquisition rights: First Stock Acquisition Rights / Resolution date: 10 August 2022 / Number of stock acquisition rights (units): 3,300 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 330,000」
For the stock options approved in the previous period, the grant details of the First Stock Acquisition Rights, consisting of 3,300 rights and 330,000 underlying shares pursuant to the resolution of 10 August 2022, were finalized and disclosed. - FY2023-Q2AdvancedAnnual report
「Name of stock acquisition rights: First Stock Acquisition Rights / Resolution date: 10 August 2022 / Number of stock acquisition rights (units): 3,300 / Class, details and number of shares underlying the stock acquisition rights (shares): Common shares, 330,000」
For the stock options approved in the previous period, the specific terms of the First Stock Acquisition Rights, consisting of 3,300 rights and 330,000 underlying shares pursuant to the resolution of 10 August 2022, were disclosed. - FY2022First statedAnnual report
「At a meeting of the Board of Directors held on 13 May 2022, the Company resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to submit a proposal to the Company's 77th Annual General Meeting of Shareholders, held on 24 June 2022, concerning the issuance of stock acquisition rights as stock options to the Company's directors, excluding directors who are Audit and Supervisory Committee members, directors who are Audit and Supervisory Committee members, and executive officers. The proposal was approved at the meeting.」
A stock option plan was approved for directors, Audit and Supervisory Committee members and executive officers, capped at 3,400 stock acquisition rights and 340,000 underlying shares. The exercise period runs from 2 to 10 years after the date of the allotment resolution.